New algorithm for periprocedural anticoagulation management in nonvalvular Afib

Access to the full content of this site is available only to registered healthcare professionals. Access to the full content of this site is available only to registered healthcare professionals.

Takeaway 

  • Managing anticoagulation in patients with atrial fibrillation (Afib) undergoing surgical procedures is an ongoing challenge across specialties, and this consensus algorithm offers step-by-step guidance.

Highlights

  • Focused on patients with nonvalvular Afib for whom anticoagulation is a clinical indication and who are having elective surgeries.
  • Summary graphic included in paywalled article.
  • Algorithm addresses key decision points:
  • --Whether to interrupt: Evaluate bleed risk (eg, HAS-BLED), use clinical judgment; if risk low, no need to interrupt. If high, decide when to interrupt.
  • --When to interrupt: Consider anticoagulant, kidney function, internal normalized ratio (INR). INR determines time frame for interruption (eg, at goal INR=might discontinue 5 d before procedure); specific actions for vitamin K antagonists (VKA) vs direct oral anticoagulants (DOACs).
  • --Whether to bridge: Consider thrombotic, bleed risk; VKA vs DOAC. 
  • --How to bridge: Consider allergies, creatinine clearance; no bridging with DOAC; with VKA, based on thrombotic risk.
  • --How to restart: Consider procedure type, medication type, bleed risk, etc (eg, with stable, low-risk patient, consider delaying reinitiation of anticoagulation).

Study design

  • Guidance consensus statement.
  • Funding: None specified; tables of task force declarations.